Long-term efficacy and safety of once-daily oral extended-release hydromorphone.

被引：0
|
作者：
Swanton, R [1 ]
Buckley, B [1 ]
机构：
[1] Purdue Pharma LP, Stamford, CT 06901 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2002年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
75
引用
收藏
页码：1068 / 1068
页数：1
相关论文
共 50 条
  • [1] Long-Term Safety and Tolerability of Once-Daily Mesalamine Extended-Release Capsules in Patients With Ulcerative Colitis
    Lichtenstein, Gary R.
    Barrett, Andrew C.
    Bortey, Enoch
    Paterson, Craig
    Forbes, William P.
    GASTROENTEROLOGY, 2013, 144 (05) : S432 - S432
  • [2] Clinical pharmacology and pharmacokinetics of once-daily hydromorphone hydrochloride extended-release capsules
    Vashi, V
    Harris, S
    El-Tahtawy, A
    Wu, DL
    Cipriano, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (05): : 547 - 554
  • [3] Efficacy and safety of an extended-release formulation of Fluvastatin for once-daily treatment of primary hypercholesterolemia
    Ballantyne, CM
    McKenney, J
    Trippe, BS
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (07): : 759 - 763
  • [4] Efficacy and safety of long-term, once-daily morphine sulfate extended-release capsules in cancer patients with chronic, moderate-to-severe pain
    Groves, ES
    Shelby, SM
    Schlosser, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 747S - 747S
  • [5] Safety and Efficacy of Once-Daily Trospium Chloride Extended-release in Male Patients With Overactive Bladder
    MacDiarmid, Scott A.
    Ellsworth, Pamela I.
    Ginsberg, David A.
    Oefelein, Michael G.
    Sussman, David O.
    UROLOGY, 2011, 77 (01) : 24 - 29
  • [6] Efficacy and safety of once-daily (qd) pramipexole extended-release for advanced Parkinson's disease
    Schapira, A.
    Barone, P.
    Hauser, R.
    Mizuno, Y.
    Poewe, W.
    Rascol, O.
    Busse, M.
    Juhel, N.
    Salin, L.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S133 - S133
  • [7] A Randomized Study of the Effects of Food on the Pharmacokinetics of Once-Daily Extended-Release Hydromorphone in Healthy Volunteers
    Moore, Kenneth Todd
    St-Fleur, Dominique
    Marricco, Nadia Cardillo
    Ariyawansa, Jay
    Page, Veronique
    Natarajan, Jayalakshmi
    Morelli, Gaetano
    Richarz, Ute
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (11): : 1571 - 1579
  • [8] Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain
    Wallace, M.
    Rauck, R. L.
    Moulin, D.
    Thipphawong, J.
    Khanna, S.
    Tudor, I. C.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2008, 36 (02) : 343 - 352
  • [9] LONG-TERM SAFETY AND EFFICACY OF EXTENDED-RELEASE ONCE-NIGHTLY SODIUM OXYBATE FOR NARCOLEPSY
    Corser, B. C.
    Morse, A. M.
    Stern, T.
    Ajayi, A. O.
    Kushida, C. A.
    Gudeman, J.
    SLEEP MEDICINE, 2024, 115 : 220 - 220
  • [10] ONCE-DAILY, EXTENDED-RELEASE GEMFIBROZIL IN PATIENTS WITH DYSLIPIDEMIA
    GOTTO, AM
    BREEN, WJ
    CORDER, CN
    DUNN, JK
    GOLDBERG, A
    KNOPP, RH
    SCHROTT, H
    SPRECHER, D
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (12): : 1057 - 1063
12345